WWJ 950'S THAW RADIOTHON: CALL 888-579-4950 NOW | LIVE UPDATES | BID IN THE ONLINE AUCTION  

Reverse Cholesterol Transport

AlphaCore Reports Positive Phase 1 Results For New Heart DrugAlphaCore Pharma announced Tuesday that results from the company’s Phase 1 clinical trial have met the primary endpoint by demonstrating the safety and tolerability of the drug ACP-501 (recombinant human LCAT).

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen